The purpose of this task order is to request the fill/finish of one (1) cgmp adjuvant bulk lot under clin 0006E. Fill/finish and release AS03 drug product.
Ended Awarded Last action
- Contract number
- 75A50124F61009
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $444,568
Award facts
- Contract value 100% obligated
- $444,568.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$37,032 | |
| Original award | $481,600 |
About this award
This is a firm fixed-price delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this task order is to request the fill/finish of one CGMP adjuvant bulk lot under CLIN 0006E and to fill/finish and release the AS03 drug product. The contract has a ceiling value of $444,568.40 and an ultimate completion date of June 30, 2024. This contract is not set aside and is part of a larger indefinite delivery contract vehicle with ASPR, which covers a broad range of vaccine procurement, including adult and pediatric influenza vaccines, standard adult vaccines, and Vaccines for Children (VFC) program supplies. Glaxosmithkline has established itself as a critical supplier of pharmaceutical products, including vaccines and antiviral medications, to various federal agencies.
Quick answers
Who was awarded contract 75A50124F61009?
75A50124F61009 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 19, 2024.
How much is contract 75A50124F61009 worth?
The government has obligated $444,568 on 75A50124F61009.
Is contract 75A50124F61009 an order under another contract?
Yes. 75A50124F61009 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61009 competed?
The extent of competition for 75A50124F61009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award